Brief: Illumina And Labcorp Expand Collaboration To Broaden Access To Precision Oncology Testing
18/03/2026 13:18
March 18 (Reuters) - Illumina Inc ILMN.O: ILLUMINA AND LABCORP EXPAND COLLABORATION TO BROADEN ACCESS TO PRECISION ONCOLOGY TESTING ILLUMINA INC - NEW TEST DEVELOPMENT TO INCLUDE IVD TESTS FOR CGP AND WGS IN ONCOLOGY ILLUMINA INC - OFFERING TO PROVIDE PHARMACEUTICAL COMPANIES OPPORTUNITIES FOR COMPANION DIAGNOSTIC DEVELOPMENT Source text: ID:nPn7QV3v6a Further company coverage: ILMN.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Labcorp Holdings
See all newsBrief: Labcorp And Epic Expand Collaboration To Advance Diagnostic Integration Across Hospitals And Health Systems
U.S. STOCKS ON THE MOVE-Quanta, O'Reilly Automotive, Avis
Labcorp lifts full‑year forecast as diagnostics business stays resilient (updated)
U.S. STOCKS ON THE MOVE-Qualcomm, Meta, Cardinal Health
U.S. STOCKS ON THE MOVE-Royal Caribbean, Labcorp, Textron